| Pharmaceutical active ingredients: |
| Vinorelbine Tartrate |
| Available forms, composition and doses of Navelbin: |
| Capsules; Oral; Vinorelbine Tartrate 20 mgCapsules; Oral; Vinorelbine Tartrate 30 mgCapsules; Oral; Vinorelbine Tartrate 40 mgCapsules; Oral; Vinorelbine Tartrate 80 mgInjectable; Injection; Vinorelbine Tartrate 10 mg / ml |
| Navelbin medical category: |
| Human:Antineoplastic agentsCytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01CA04 - Vinorelbine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Pierre FabreEwopharma |
| Related documents and information about Navelbin: |
| Navelbine prescribing information (PDF) |